PL372930A1 - N-{[(2S)-4-(3,4-Difluorobenzylo) morfolin-2-ylo] metylo}-2-{3-[(metylosulfonylo) amino] fenylo} acetamid jako antagonista CCR3 do leczenia stanów zapalnych - Google Patents

N-{[(2S)-4-(3,4-Difluorobenzylo) morfolin-2-ylo] metylo}-2-{3-[(metylosulfonylo) amino] fenylo} acetamid jako antagonista CCR3 do leczenia stanów zapalnych

Info

Publication number: PL372930A1
Authority: PL; Poland
Prior art keywords: methylsulphonyl; difluorobenzyl; morpholin; acetamide; phenyl
Prior art date: 2002-03-28

Application number

PL03372930A

Other languages

English (en)

Inventor

Rachael Ann Ancliff

Caroline Mary Cook

Colin David Eldred

Paul Martin Gore

Lee Andrew Harrison

Martin Alistair Hayes

Simon Teanby Hodgson

Duncan Bruce Judd

Suzanne Elaine Keeling

Xiao Qing Lewell

Gail Mills

Graeme Michael Robertson

Stephen Swanson

Andrew John Walker

Mark Wilkinson

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-28

Filing date

2003-03-27

Publication date

2005-08-08

2003-03-27 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2005-08-08 Publication of PL372930A1 publication Critical patent/PL372930A1/pl

Links

NDZYPHLNJZSQJY-QNWVGRARSA-N 1-(5-acetyl-4-methyl-1,3-thiazol-2-yl)-3-[(1r,2s)-2-[[(3s)-3-[(4-fluorophenyl)methyl]piperidin-1-yl]methyl]cyclohexyl]urea Chemical compound CC1=C(C(=O)C)SC(NC(=O)N[C@H]2[C@@H](CCCC2)CN2C[C@H](CC=3C=CC(F)=CC=3)CCC2)=N1 NDZYPHLNJZSQJY-QNWVGRARSA-N 0.000 title 1
125000006509 3,4-difluorobenzyl group Chemical group [H]C1=C(F)C(F)=C([H])C(=C1[H])C([H])([H])* 0.000 title 1
METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 title 1
230000004968 inflammatory condition Effects 0.000 title 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
-1 methylsulphonyl Chemical group 0.000 title 1
125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 title 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Immunology (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

PL03372930A 2002-03-28 2003-03-27 N-{[(2S)-4-(3,4-Difluorobenzylo) morfolin-2-ylo] metylo}-2-{3-[(metylosulfonylo) amino] fenylo} acetamid jako antagonista CCR3 do leczenia stanów zapalnych PL372930A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0207449.0A GB0207449D0 (en)	2002-03-28	2002-03-28	Novel compounds

Publications (1)

Publication Number	Publication Date
PL372930A1 true PL372930A1 (pl)	2005-08-08

Family

ID=9933998

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03372930A PL372930A1 (pl)	2002-03-28	2003-03-27	N-{[(2S)-4-(3,4-Difluorobenzylo) morfolin-2-ylo] metylo}-2-{3-[(metylosulfonylo) amino] fenylo} acetamid jako antagonista CCR3 do leczenia stanów zapalnych

Country Status (22)

Country	Link
US (1)	US20060058299A1 (pl)
EP (1)	EP1487453B1 (pl)
JP (1)	JP4490110B2 (pl)
KR (1)	KR20040095347A (pl)
CN (1)	CN1642553A (pl)
AR (1)	AR039177A1 (pl)
AT (1)	ATE454892T1 (pl)
AU (1)	AU2003216905A1 (pl)
BR (1)	BR0308719A (pl)
CA (1)	CA2479910A1 (pl)
DE (1)	DE60330952D1 (pl)
ES (1)	ES2339436T3 (pl)
GB (1)	GB0207449D0 (pl)
IL (1)	IL163648A0 (pl)
IS (1)	IS7415A (pl)
MX (1)	MXPA04009458A (pl)
NO (1)	NO20044098L (pl)
PL (1)	PL372930A1 (pl)
RU (1)	RU2004126145A (pl)
TW (1)	TW200400823A (pl)
WO (1)	WO2003082291A1 (pl)
ZA (1)	ZA200406990B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004028530A1 (en)	2002-09-26	2004-04-08	Bristol-Myers Squibb Company	N-substituted heterocyclic amines as modulators of chemokine receptor activity
JP2009501792A (ja) *	2005-07-21	2009-01-22	アストラゼネカ・アクチエボラーグ	ケモカイン受容体のモジュレーターとしてのｎ−ベンジル−モルホリン誘導体
HUP0500877A2 (en) *	2005-09-22	2007-05-29	Sanofi Aventis	Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
AU2006293635A1 (en) *	2005-09-22	2007-03-29	Sanofi-Aventis	Amino-alkyl-amide derivatives as CCR3 receptor liquids
HUP0500886A2 (en) *	2005-09-23	2007-05-29	Sanofi Aventis	Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use
HUP0800478A2 (en) *	2008-07-31	2010-03-01	Sanofi Aventis	Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands
WO2013079696A1 (en) *	2011-12-01	2013-06-06	Glaxo Group Limited	Methods of treatment and prevention of eye diseases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS562929A (en) *	1979-06-21	1981-01-13	Sumitomo Chem Co Ltd	Preparation of optically active cyclopentenolone
CZ284687B6 (cs) *	1986-04-30	1999-02-17	Dainippon Pharmaceutical Co., Ltd.	Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi
JPH01117882A (ja) *	1987-10-30	1989-05-10	Dainippon Pharmaceut Co Ltd	複素環式カルボン酸アミド誘導体
JPH03291274A (ja) *	1990-04-09	1991-12-20	Yoshitomi Pharmaceut Ind Ltd	アミノアルキルモルホリン誘導体の製造法
JPH04270272A (ja) *	1991-02-25	1992-09-25	Yoshitomi Pharmaceut Ind Ltd	アミノアルキルモルホリン誘導体の製造法
TW223629B (pl) *	1992-03-06	1994-05-11	Hoffmann La Roche
US5219856A (en) *	1992-04-06	1993-06-15	E. I. Du Pont De Nemours And Company	Angiotensin-II receptor blocking, heterocycle substituted imidazoles
US6031097A (en) *	1997-10-27	2000-02-29	Neurogen Corporation	1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands
CA2347912A1 (en) *	1998-12-18	2000-06-22	Soo S. Ko	Heterocyclic piperidines as modulators of chemokine receptor activity
PT1216249E (pt) *	1999-09-14	2004-04-30	Aventis Pharma Inc	Derivados de etilicos e propilicos insubstituidos de tienoisoxazol-fenoxi uteis como antagonistas d4
CZ20031194A3 (cs) *	2000-09-29	2003-08-13	Glaxo Group Limited	Deriváty močoviny
IL155093A0 (en) *	2000-09-29	2003-10-31	Glaxo Group Ltd	Morpholin-acetamide derivatives for the treatment on inflammatory diseases

2002
- 2002-03-28 GB GBGB0207449.0A patent/GB0207449D0/en not_active Ceased
2003
- 2003-03-26 TW TW092106782A patent/TW200400823A/zh unknown
- 2003-03-27 CA CA002479910A patent/CA2479910A1/en not_active Abandoned
- 2003-03-27 AU AU2003216905A patent/AU2003216905A1/en not_active Abandoned
- 2003-03-27 JP JP2003579828A patent/JP4490110B2/ja not_active Expired - Lifetime
- 2003-03-27 AR ARP030101090A patent/AR039177A1/es unknown
- 2003-03-27 BR BR0308719-0A patent/BR0308719A/pt not_active Application Discontinuation
- 2003-03-27 EP EP03712117A patent/EP1487453B1/en not_active Expired - Lifetime
- 2003-03-27 DE DE60330952T patent/DE60330952D1/de not_active Expired - Lifetime
- 2003-03-27 CN CNA038068656A patent/CN1642553A/zh active Pending
- 2003-03-27 WO PCT/EP2003/003339 patent/WO2003082291A1/en not_active Ceased
- 2003-03-27 PL PL03372930A patent/PL372930A1/pl not_active Application Discontinuation
- 2003-03-27 MX MXPA04009458A patent/MXPA04009458A/es unknown
- 2003-03-27 AT AT03712117T patent/ATE454892T1/de not_active IP Right Cessation
- 2003-03-27 ES ES03712117T patent/ES2339436T3/es not_active Expired - Lifetime
- 2003-03-27 US US10/509,417 patent/US20060058299A1/en not_active Abandoned
- 2003-03-27 RU RU2004126145/04A patent/RU2004126145A/ru not_active Application Discontinuation
- 2003-03-27 KR KR10-2004-7015447A patent/KR20040095347A/ko not_active Withdrawn
- 2003-03-27 IL IL16364803A patent/IL163648A0/xx unknown
2004
- 2004-08-19 IS IS7415A patent/IS7415A/is unknown
- 2004-09-01 ZA ZA200406990A patent/ZA200406990B/en unknown
- 2004-09-27 NO NO20044098A patent/NO20044098L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP4490110B2 (ja)	2010-06-23
AU2003216905A1 (en)	2003-10-13
ZA200406990B (en)	2005-11-08
JP2005525390A (ja)	2005-08-25
US20060058299A1 (en)	2006-03-16
AR039177A1 (es)	2005-02-09
GB0207449D0 (en)	2002-05-08
KR20040095347A (ko)	2004-11-12
BR0308719A (pt)	2005-01-04
CA2479910A1 (en)	2003-10-09
NO20044098L (no)	2004-10-04
WO2003082291A1 (en)	2003-10-09
TW200400823A (en)	2004-01-16
EP1487453B1 (en)	2010-01-13
EP1487453A1 (en)	2004-12-22
RU2004126145A (ru)	2005-06-27
ES2339436T3 (es)	2010-05-20
IL163648A0 (en)	2005-12-18
DE60330952D1 (de)	2010-03-04
CN1642553A (zh)	2005-07-20
MXPA04009458A (es)	2005-07-27
IS7415A (is)	2004-08-19
ATE454892T1 (de)	2010-01-15

Legal Events

Date	Code	Title	Description
2010-07-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
PL371527A1 (pl)	2005-06-27	Bicykliczne heterocykliczne podstawione fenylooksazolidynonowe środki przeciwbakteryjne oraz pokrewne kompozycje i metody
PL374436A1 (pl)	2005-10-17	Nowa polimorficzna postać N-metylo-N-(3-{3-[2-tienylokarbonylo]pirazolo-[1,5-a]pirymidyn-7-ylo}fenylo)acetamidu, jej kompozycje i sposoby wytwarzania
ATE361279T1 (de)	2007-05-15	N-[phenyl(piperidin-2-yl)methyl]benzamidderivat , verfahren zu ihrer herstellung und ihre therapeutische anwendung
IL164608A0 (en)	2005-12-18	2-(2,6-Dichlorophenyl)-diarylimidazoles
EP1551801A4 (en)	2007-06-20	NOVEL GAMMA-LACTAMES AS INHIBITORS OF BETA-SECRETASE
WO2004004665A3 (en)	2004-03-25	Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
HK10777456A1 (en)	2007-11-30	Sustained-release table composition of pramipexole
IL165925A0 (en)	2006-01-15	Phenyl benzamides
EE200300347A (et)	2003-12-15	Aniliini derivaadid, mis on kasulikud kui fosfodiesteraas 4 inhibiitorid
ZA200502320B (en)	2006-10-25	Process for decreasing aggregate levels of pegylated protein
DE60316116D1 (de)	2007-10-18	Amide von aminoalkylsubstituierten azetidinen, pyrrolidinen, piperidinen und azepanen
PL374589A1 (pl)	2005-10-31	8/17 związki heterocykliczne i ich zastosowanie jako inhibitorów ligazy D-Alanylo-D-Alaninowej
ZA200509103B (en)	2006-09-27	Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamideor salts thereof
PL377519A1 (pl)	2006-02-06	Związki N-(indoloetylo-)cykloaminowe
ATE381263T1 (de)	2008-01-15	Fungizide zusammensetzungen, die n-(alpha-cyano-2-thenyl)-4-ethyl-2-ethylamino-5 thiazolcarboxamide enthalten
IL163891A0 (en)	2005-12-18	Siliconated phenyl amides derivatives useful as microbiocide
IL213960A0 (en)	2011-08-31	2-(substituted phenyl)-2-hydroxyl -ethyl carbamates
HRP20040920A2 (en)	2005-02-28	Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
PT1545710E (pt)	2009-05-26	Utilização de n-(3-metoxi-5-metilpirazin-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil) piridino-3-sulfonamida no tratamento de cancro
IS7415A (is)	2004-08-19	N-{'(2S)-4-(3,4-díflúrbensýl)morfólín-2ýl!metýl}-2-{3-'(metýlsúlfónýl)amínó!fenýl} asetamíð sem CCR3 mótlyf fyrir meðhöndlun bólgusjúkdóma
TW200507755A (en)	2005-03-01	Fungicidal mixtures
AU2003235814A8 (en)	2003-07-24	Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-(2-( 4-(((((4-methyl cyclohexyl) amino)carbonyl) amino)sulfonyl) phenyl)ethyl) -2-oxo-1h-pyrrole -1-carboxamide
HK1071699A (en)	2005-07-29	N-[(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl]methyl-2-3-[(methylsulphonyl)amino]phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions
HUP0202698A3 (en)	2004-12-28	Polymorphs of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
PL377708A1 (pl)	2006-02-06	Oksazole jako wzmacniacze mGluR1